الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 136 |  |  |
| | | from | 136 | | |
Abstract
Liver transplantation remains the treatment of choice for many patients with end-stage liver disease. Published reports suggest that 9–38% of patients after LDLT develop biliary complications. The reported complication rate does not seem to improve significantly with experience. Thus, it remains a major focus of research aiming to minimize long-term morbidity. In many centres, non-surgical methods have become the standard of care for most biliary complications. Surgery is usually reserved for those patients with whom endoscopic and/or percutaneous treatments have not been successful. However, there are no randomized studies comparing both approaches, and there is no definitive consensus regarding the therapeutic management of biliary complications Today, post LDLT biliary complications are infrequent causes of death because they can be accurately and promptly diagnosed, and corrective measures are instituted before they become life threatening. The overall risk for mortality caused by biliary complications has been reduced to a small percentage of all patients who undergo liver grafting. The aim of this work was to study the incidence and the management of biliary complications in recipients after living donor liver transplantation, with special emphasis on the role of surgery in the management of those patients. The records of 185 patients who underwent LDLT in National Liver Institute, Menufiya University, from April 2003 to August 2012, were retrospectively revised. Those patients were 153 males (82.7%) and 32 females (17.3%). 154 of whom were adults (82.2%) and 31 were children (16.8%).